Maternal and fetal outcome after long-term bisphosphonate exposure before conception

[1]  A. Ornoy,et al.  The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment. , 2006, Reproductive toxicology.

[2]  Emily C Culbert,et al.  Malignant Hypercalcemia in Pregnancy: Effect of Pamidronate on Uterine Contractions , 2006, Obstetrics and gynecology.

[3]  M. Zacharin,et al.  Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. , 2006, The Journal of clinical endocrinology and metabolism.

[4]  I. Reid,et al.  Bisphosphonates in pregnancy and lactation-associated osteoporosis , 2006, Osteoporosis International.

[5]  S. Cremers,et al.  Skeletal Retention of Bisphosphonate (Pamidronate) and Its Relation to the Rate of Bone Resorption in Patients With Breast Cancer and Bone Metastases , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  F. Glorieux,et al.  Maternal and Fetal Outcome After Long‐Term Pamidronate Treatment Before Conception: A Report of Two Cases , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  G. Golomb,et al.  Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. , 1999, Teratology.

[8]  R. Hicks,et al.  Technetium-99m-methylene diphosphonate uptake in the fetal skeleton at 30 weeks gestation. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.